Immuno-Biological Laboratories Co., Ltd. had a revenue of 236.00M in the quarter ending Dec 31, 2024, with 9.77%. This bring the company's revenue in the last twelve months to 948.30M, Decreased 5.93%. In the fiscal year ending Mar 31, 2025, Immuno-Biological Laboratories Co., Ltd. had annual revenue of 969.53M with 18.71% growth.